86 studies found for:    cancer | butyrate
Show Display Options
Rank Status Study
21 Completed
Has Results
A Pilot Study to Evaluate Efficacy and Safety of Clevidipine in Neurosurgical Patients
Conditions: Hypertension;   Brain Tumor;   Epilepsy
Intervention: Drug: Clevidipine
22 Unknown  Intrathecal and Systemic Chemotherapy Combined With Radiation Therapy in Treating Young Patients With Newly Diagnosed Central Nervous System Atypical Teratoid/Rhabdoid Tumors
Condition: Brain and Central Nervous System Tumors
Interventions: Biological: dactinomycin;   Biological: filgrastim;   Drug: cisplatin;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: dexrazoxane hydrochloride;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: temozolomide;   Drug: therapeutic hydrocortisone;   Drug: vincristine sulfate;   Radiation: radiation therapy
23 Terminated Combination of Docetaxel + Estramustine + Hydrocortisone Versus Docetaxel + Prednisone in Patients With Advanced Prostate Cancer
Condition: Prostatic Neoplasms
Interventions: Drug: Docetaxel + Estramustine + Hydrocortisone;   Drug: Docetaxel + Prednisone
24 Recruiting Miracle Mouthwash Plus Hydrocortisone vs Prednisolone Mouth Rinse for Mouth Sores Caused by Everolimus
Conditions: Stomatitis;   Oral Mucositis;   Neoplasm of the Breast;   Malignant Tumor of Breast
Interventions: Drug: Miracle Mouthwash Plus Hydrocortisone;   Drug: Prednisolone
25 Active, not recruiting Spironolactone in Preventing Rash in Patients With Advanced Cancer Receiving Panitumumab and Cetuximab
Conditions: Dermatologic Complications;   Malignant Neoplasm
Interventions: Drug: spironolactone;   Other: placebo;   Other: questionnaire administration;   Drug: sunscreen;   Procedure: management of therapy complications;   Drug: doxycycline;   Drug: therapeutic hydrocortisone
26 Recruiting Effect of Perioperative Glucocorticoid Replacement on Prognosis of Surgical Patients With Sellar Lesions
Conditions: Pituitary Neoplasms;   Craniopharyngiomas
Interventions: Drug: Hydrocortisone;   Drug: Prednisone
27 Recruiting Pituitary Steroid Study
Conditions: Pituitary Adenoma;   Pituitary Diseases
Interventions: Drug: hydrocortisone;   Drug: dexamethasone
28 Completed Systemic and Topical Treatments for Rash Secondary to Erlotinib in Lung Cancer
Condition: Rash
Interventions: Drug: minocycline; Lotion (clindamycin 2% /hydrocortisone 1%);   Drug: minocycline;   Drug: clindamycin 2% and hydrocortisone 1%,
29 Completed Chemotherapy Plus Bone Marrow Transplantation in Treating Patients With Refractory Non-Hodgkin's Lymphoma, Hodgkin's Disease, or Multiple Myeloma
Conditions: Lymphoma;   Multiple Myeloma and Plasma Cell Neoplasm
Interventions: Biological: filgrastim;   Biological: sargramostim;   Drug: carmustine;   Drug: cyclophosphamide;   Drug: cytarabine;   Drug: etoposide;   Drug: leucovorin calcium;   Drug: methotrexate;   Drug: perfosfamide;   Drug: therapeutic hydrocortisone;   Procedure: allogeneic bone marrow transplantation;   Procedure: autologous bone marrow transplantation;   Procedure: in vitro-treated bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Procedure: syngeneic bone marrow transplantation;   Radiation: radiation therapy
30 Completed Chemotherapy in Treating Children With Down Syndrome and Myeloproliferative Disorder, Acute Myelogenous Leukemia, or Myelodysplastic Syndrome
Conditions: Leukemia;   Myelodysplastic Syndromes;   Myelodysplastic/Myeloproliferative Neoplasms
Interventions: Drug: asparaginase;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: methotrexate;   Drug: therapeutic hydrocortisone;   Drug: thioguanine
31 Completed 506U78 in Treating Patients With Refractory Hematologic Cancer
Conditions: Recurrent Childhood Acute Lymphoblastic Leukemia;   Recurrent Childhood Lymphoblastic Lymphoma;   T-cell Childhood Acute Lymphoblastic Leukemia
Interventions: Drug: nelarabine;   Drug: methotrexate;   Drug: cytarabine;   Drug: therapeutic hydrocortisone
32 Completed
Has Results
Evaluation of Tumor Response to Ipilimumab in the Treatment of Melanoma With Brain Metastases
Condition: Melanoma
Interventions: Drug: Ipilimumab;   Drug: Corticosteroid: Betamethasone;   Drug: Corticosteroid: Dexamethasone;   Drug: Corticosteroid: Fludrocortisone;   Drug: Corticosteroid: Hydrocortisone;   Drug: Corticosteroid: Meprednisone;   Drug: Corticosteroid: Methylprednisolone;   Drug: Corticosteroid: Prednisolone;   Drug: Corticosteroid: Prednisone;   Drug: Corticosteroid: Triamcinolone
33 Recruiting Bortezomib and Vorinostat in Younger Patients With Refractory or Relapsed MLL Rearranged Hematologic Malignancies
Conditions: Mixed Lineage Acute Leukemia;   Acute Myeloid Leukemia;   Acute Lymphoid Leukemia
Interventions: Drug: Bortezomib;   Drug: Vorinostat;   Drug: Mitoxantrone;   Drug: Cytarabine;   Drug: Methotrexate;   Drug: Hydrocortisone;   Drug: Peg-L-Asparaginase;   Drug: Erwinia L-Asparaginase;   Drug: Dexamethasone;   Drug: Mercaptopurine;   Drug: Doxorubicin
34 Recruiting Crenolanib in Combination With Sorafenib in Patients With Refractory or Relapsed Hematologic Malignancies
Condition: Acute Myeloid Leukemia
Interventions: Drug: Crenolanib;   Drug: Sorafenib;   Drug: methotrexate, hydrocortisone and cytarabine with leucovorin
35 Terminated S9427, Suramin in Treating Patients With Stage III or Stage IV Adrenocortical Cancer Incurable by Surgery
Condition: Adrenocortical Carcinoma
Interventions: Drug: suramin;   Drug: therapeutic hydrocortisone
36 Completed Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myelogenous Leukemia or Myelodysplastic Syndrome
Conditions: Childhood Acute Erythroleukemia (M6);   Childhood Acute Megakaryocytic Leukemia (M7);   Childhood Acute Monoblastic Leukemia (M5a);   Childhood Acute Monocytic Leukemia (M5b);   Childhood Acute Myeloblastic Leukemia With Maturation (M2);   Childhood Acute Myeloblastic Leukemia Without Maturation (M1);   Childhood Acute Myelomonocytic Leukemia (M4);   Childhood Myelodysplastic Syndromes;   Chronic Myelomonocytic Leukemia;   de Novo Myelodysplastic Syndromes;   Refractory Anemia;   Refractory Anemia With Excess Blasts;   Refractory Anemia With Excess Blasts in Transformation;   Refractory Anemia With Ringed Sideroblasts;   Secondary Myelodysplastic Syndromes;   Untreated Childhood Acute Myeloid Leukemia and Other Myeloid Malignancies
Interventions: Drug: asparaginase;   Drug: daunorubicin hydrochloride;   Drug: fludarabine phosphate;   Drug: therapeutic hydrocortisone;   Procedure: allogeneic bone marrow transplantation;   Radiation: 3-dimensional conformal radiation therapy;   Biological: filgrastim;   Drug: cytarabine;   Drug: idarubicin;   Drug: dexamethasone;   Drug: thioguanine;   Drug: etoposide;   Drug: methotrexate;   Drug: cyclophosphamide;   Biological: aldesleukin;   Drug: busulfan
37 Not yet recruiting Combination Chemotherapy, Rituximab, and Ixazomib Citrate in Treating Patients With Non-Hodgkin Lymphoma
Conditions: Adult Burkitt Lymphoma;   B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between Diffuse Large B-Cell Lymphoma and Burkitt Lymphoma;   Diffuse Large B-Cell Lymphoma;   MYC Gene Mutation;   Plasmablastic Lymphoma
Interventions: Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Doxorubicin Hydrochloride;   Drug: Etoposide;   Drug: Ixazomib Citrate;   Other: Laboratory Biomarker Analysis;   Drug: Methotrexate;   Drug: Prednisone;   Biological: Rituximab;   Drug: Therapeutic Hydrocortisone;   Drug: Vincristine Sulfate
38 Completed Combination Chemotherapy in Treating Patients With Acute Myeloid Leukemia or Myelodysplastic Syndrome
Condition: Leukemia
Interventions: Biological: filgrastim;   Drug: cladribine;   Drug: cytarabine;   Drug: etoposide;   Drug: methotrexate;   Drug: mitoxantrone hydrochloride;   Drug: therapeutic hydrocortisone;   Procedure: allogeneic bone marrow transplantation;   Procedure: autologous bone marrow transplantation;   Procedure: peripheral blood stem cell transplantation;   Radiation: low-LET cobalt-60 gamma ray therapy;   Radiation: low-LET electron therapy;   Radiation: low-LET photon therapy
39 Completed Combination Chemotherapy With or Without Bone Marrow Transplantation in Treating Children With Acute Myeloid Leukemia
Conditions: Leukemia;   Myelodysplastic Syndromes
Interventions: Drug: amsacrine;   Drug: asparaginase;   Drug: cytarabine;   Drug: daunorubicin hydrochloride;   Drug: etoposide;   Drug: methotrexate;   Drug: mitoxantrone hydrochloride;   Drug: therapeutic hydrocortisone;   Procedure: allogeneic bone marrow transplantation
40 Recruiting Blinatumomab in Treating Younger Patients With Relapsed B-cell Acute Lymphoblastic Leukemia
Conditions: Adult B Acute Lymphoblastic Leukemia;   Childhood B Acute Lymphoblastic Leukemia;   Recurrent Adult Acute Lymphoblastic Leukemia;   Recurrent Childhood Acute Lymphoblastic Leukemia
Interventions: Procedure: Allogeneic Hematopoietic Stem Cell Transplantation;   Drug: Asparaginase;   Biological: Blinatumomab;   Drug: Cyclophosphamide;   Drug: Cytarabine;   Drug: Dexamethasone;   Drug: Etoposide;   Other: Laboratory Biomarker Analysis;   Drug: Leucovorin Calcium;   Drug: Mercaptopurine;   Drug: Methotrexate;   Drug: Mitoxantrone Hydrochloride;   Drug: Pegaspargase;   Other: Pharmacological Study;   Drug: Therapeutic Hydrocortisone;   Drug: Thioguanine;   Drug: Vincristine Sulfate

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years